Posts

Kim Kardashian sparks debate on the benefits of full-bo...

Kim Kardashian’s Instagram post this week about Prenuvo, which sells full-body M...

STAT+: Pharmalittle: Supreme Court halts Purdue bankrup...

The Supreme Court blocked a settlement with Purdue Pharma designed to shield mem...

Bird flu researchers turn to Finland’s mink farms, trac...

Bird flu researchers turn to Finland’s mink farms, tracking a virus with pandemi...

Opinion: Philanthropic endowments at universities can o...

With pharmaceutical companies being more risk-averse, academic drug discovery ha...

Tuberculosis outbreak tied to bone grafts underscores s...

One person has died and at least four have been sickened by tuberculosis in infe...

STAT+: Supreme Court blocks Purdue bankruptcy plan that...

The Supreme Court blocked a nationwide settlement with Purdue Pharma that was de...

STAT+: EPA fines Roche’s Genentech unit for hazardous w...

The EPA fined Genentech more than $158,000 for hazardous waste violations at a f...

STAT+: AdventHealth sues MultiPlan, alleging a ‘cartel’...

AdventHealth has sued MultiPlan, alleging the company has worked with health ins...

STAT+: What to know about concerns raised by compounded...

Here's what you need to know regarding the concerns raised about compounded vers...

Listen: Your guide to Wegovy’s blockbuster heart study

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And...

Covid took a toll on heart health — and doctors are sti...

“We’re about to exit this pandemic as even a sicker nation” because of virus-rel...

STAT+: A yogurt drink instead of a colonoscopy? Study u...

Using yogurt to replace a colonoscopy may sound far-fetched, but scientists just...

Pharma budget tightening trickles down to Doximity

In the latest edition of STAT's Health Tech newsletter: pharma budget tightening...

STAT+: Pharmalittle: Genentech weighs delaying cancer t...

CEO says Medicare negotiation could encourage Genentech to slow-walk ovarian can...

STAT+: Anavex, maker of rare disease drug, keeps shifti...

Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial...

STAT+: Novo acquires Inversago for up to $1 billion, sp...

Novo Nordisk doubled down on its obesity drug pipeline Thursday, acquiring a sma...